CLINICAL_TRIALS
trial_result
· 2015-12-16
Clinical Trial Update: Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART)
Summary
The document notes the completion of an observational study of bevacizumab (Avastin) for metastatic colorectal cancer. Results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Status: COMPLETED | Results posted: 2015-12-16